<?xml version="1.0" ?>
<document id="810749401200c77f19d5a7950070e0c2d4d2629e">
  <chunk id="810749401200c77f19d5a7950070e0c2d4d2629e.c0" text="Ubiquitin-Specific Proteases 25 Negatively Regulates Virus-Induced Type I Interferon Signaling">
    <entity charOffset="74-84" id="810749401200c77f19d5a7950070e0c2d4d2629e.c0.e0" ontology_id="CHEBI_52999" text="Interferon" type="chemical"/>
  </chunk>
  <chunk id="810749401200c77f19d5a7950070e0c2d4d2629e.c1" text="Ubiquitination and deubiquitination have emerged as critical regulatory processes in the virus-triggered type I interferon (IFN) induction pathway. In this study, we carried out a targeted siRNA screen of 54 ubiquitin-specific proteases (USPs) and identified USP25 as a negative regulator of the virus-triggered type I IFN signaling pathway. Overexpression of USP25 inhibited virus-induced activation of IFN-β, interferon regulation factor 3 (IRF3) and nuclear factor-kappa B (NF-κB), as well as the phosphorylation of IRF3 and NF-κB subunit p65. Furthermore, Knockdown of USP25 potentiated virus-induced induction of the IFN-β. In addition, detailed analysis demonstrated that USP25 cleaved lysine 48-and lysine 63-linked polyubiquitin chains in vitro and in vivo, and its deubiquitinating enzyme (DUB) activity, were dependent on a cysteine residue (Cys178) and a histidine residue (His607). USP25 mutants lacking DUB activity lost the ability to block virus-induced type I IFN to some degree. Mechanistically, USP25 deubiquitinated retinoic acid-inducible gene I (RIG-I), tumornecrosis factor (TNF) receptor-associated factor 2 (TRAF2), and TRAF6 to inhibit RIG-I-like receptor-mediated IFN signaling. Our findings suggest that USP25 is a novel DUB negatively regulating virus-induced type I IFN production.">
    <entity charOffset="112-122" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e0" ontology_id="CHEBI_52999" text="interferon" type="chemical"/>
    <entity charOffset="411-421" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e1" ontology_id="CHEBI_52999" text="interferon" type="chemical"/>
    <entity charOffset="692-698" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e2" ontology_id="CHEBI_18019" text="lysine" type="chemical"/>
    <entity charOffset="692-698" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e3" ontology_id="CHEBI_25094" text="lysine" type="chemical"/>
    <entity charOffset="706-712" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e4" ontology_id="CHEBI_18019" text="lysine" type="chemical"/>
    <entity charOffset="706-712" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e5" ontology_id="CHEBI_25094" text="lysine" type="chemical"/>
    <entity charOffset="834-842" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e6" ontology_id="CHEBI_15356" text="cysteine" type="chemical"/>
    <entity charOffset="834-850" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e7" ontology_id="CHEBI_32460" text="cysteine residue" type="chemical"/>
    <entity charOffset="866-875" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e8" ontology_id="CHEBI_15971" text="histidine" type="chemical"/>
    <entity charOffset="866-875" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e9" ontology_id="CHEBI_27570" text="histidine" type="chemical"/>
    <entity charOffset="866-883" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e10" ontology_id="CHEBI_32535" text="histidine residue" type="chemical"/>
    <entity charOffset="929-933" id="810749401200c77f19d5a7950070e0c2d4d2629e.c1.e11" ontology_id="CHEBI_25434" text="lost" type="chemical"/>
  </chunk>
</document>
